AVEO Oncology
AVEO
#7099
Rank
HK$4.05 B
Marketcap
HK$116.77
Share price
0.00%
Change (1 day)
170.86%
Change (1 year)

AVEO Oncology (AVEO) - Total assets

Total assets on the balance sheet as of September 2022 : HK$0.78 Billion

According to AVEO Oncology 's latest financial reports the company's total assets are HK$0.78 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AVEO Oncology - Total assets on balance sheet (from 2008 to 2022)

Total assets by year

Year Total assets Change
2021-12-31HK$0.82 B58.35%
2020-12-31HK$0.51 B31.63%
2019-12-31HK$0.39 B80.14%
2018-12-31HK$0.21 B-44.22%
2017-12-31HK$0.39 B85.36%
2016-12-31HK$0.21 B-32.67%
2015-12-31HK$0.31 B-42.67%
2014-12-31HK$0.54 B-51.7%
2013-12-31HK$1.13 B-29.43%
2012-12-31HK$1.60 B-29.83%
2011-12-31HK$2.29 B94.95%
2010-12-31HK$1.17 B153.33%
2009-12-31HK$0.46 B49.79%
2008-12-31HK$0.30 B-41.27%
2007-12-31HK$0.52 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Biogen
BIIB
HK$227.36 B 28,751.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$312.70 B 39,580.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$1.90 B 141.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$754.24 B 95,608.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$894.72 B 113,435.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$701.71 B 88,943.10%๐Ÿ‡บ๐Ÿ‡ธ USA